Clinical Trial Update: Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on IMMUNO-BIOMAP evaluating biomarkers to predict response to first-line PD-1/PD-L1 immunotherapy and to guide second-line treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 | Phase 2 | Status: RECRUITING